{"nct_id":"NCT03105128","title":"A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease","status":"COMPLETED","status_verified_date":"2022-06","start_date":"2017-05-10","start_date_type":"ACTUAL","primary_completion_date":"2020-11-09","primary_completion_date_type":"ACTUAL","completion_date":"2021-04-14","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}